Showing results (231-240 of 514) with videos related to
Sort By:
Pageof 52
Immunology|January 19, 2008
Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protectionElse Marie Agger, Joseph P Cassidy, Joseph Brady, et al.ACS Nano|January 5, 2019
A Liposome-Based Adjuvant Containing Two Delivery Systems with the Ability to Induce Mucosal Immunoglobulin A Following a Parenteral ImmunizationDennis Christensen, Lasse Bøllehuus Hansen, Romain Leboux, et al.Scientific Reports|February 26, 2016
Identifying protective Streptococcus pyogenes vaccine antigens recognized by both B and T cells in human adults and childrenRasmus Mortensen, Thomas Nørrelykke Nissen, Sine Fredslund, et al.Frontiers in Immunology|May 10, 2024
Targeting PD-L1 in solid cancer with myeloid cells expressing a CAR-like immune receptorKayla Myers Chen, Daniel Grun, Brian Gautier, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2005
Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacyJes Dietrich, Claus Aagaard, Robert Leah, et al.Journal of Drug Targeting|May 1, 2008
PLGA microspheres for the delivery of a novel subunit TB vaccineDaniel J Kirby, Ida Rosenkrands, Else M Agger, et al.Journal of Drug Targeting|August 8, 2008
Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheresDaniel J Kirby, Ida Rosenkrands, Else M Agger, et al.Vaccine|April 28, 2018
Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powderAneesh Thakur, Pall Thor Ingvarsson, Signe Tandrup Schmidt, et al.Immunology and Cell Biology|August 14, 2015
A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ⁺ CMI responses protects against a genital infection in minipigsSarah Bøje, Anja Weinreich Olsen, Karin Erneholm, et al.Nanomedicine (London, England)|December 23, 2014
A stable nanoparticulate DDA/MMG formulation acts synergistically with CpG ODN 1826 to enhance the CD4⁺ T-cell responseKasper Karlsen, Karen Smith Korsholm, Rasmus Mortensen, et al.Pageof 52